CVS Health Corp (CVS)

83.92
1.94 2.37
NYSE : Health Care
Prev Close 81.98
Open 81.97
Day Low/High 81.91 / 83.98
52 Wk Low/High 69.30 / 106.67
Volume 7.29M
Avg Volume 8.51M
Exchange NYSE
Shares Outstanding 1.07B
Market Cap 87.43B
EPS 4.70
P/E Ratio 17.59
Div & Yield 2.00 (2.40%)

Latest News

Mylan Crushed by Trump, Cigna and CVS -- All In Two Days

Mylan Crushed by Trump, Cigna and CVS -- All In Two Days

The drug maker's shares have fallen 6.2% since Wednesday's market open.

CVS Is the Latest to Rock Mylan's EpiPen Empire

CVS Is the Latest to Rock Mylan's EpiPen Empire

The price of EpiPens has surged about 25% annually since 2007.

Cigna Defends Abandoning EpiPen Coverage

Cigna Defends Abandoning EpiPen Coverage

Cigna will now encourage patients to use either Impax's or Mylan's generic autoinjector. Impax offers cheaper prices, but can its manufacturing keep up?

CVS Health Offers Patients Lowest Cash Price In The Market For Generic Epinephrine Auto-injector To Treat Allergic Reactions

CVS Health Offers Patients Lowest Cash Price In The Market For Generic Epinephrine Auto-injector To Treat Allergic Reactions

Generic epinephrine auto-injector from Impax Laboratories available at CVS Pharmacy at cash price 80% lower than EpiPen®

CVS Shares Could Make Your Portfolio Sick

CVS Shares Could Make Your Portfolio Sick

Shares of CVS have taken a hit over the past year, and while the company is doing what it can to stem the slide, it hasn't been enough.

Why CVS Could Be Lethal for Your Otherwise Healthy Portfolio

Why CVS Could Be Lethal for Your Otherwise Healthy Portfolio

Avoid at all costs.

Trifecta Stocks Weekly Roundup

The market continued its run as the new year started, with a number of portfolio positions showing nice advances.

Walgreens Beats on Bottom Line

The company's consistency is a testament to management’s commitment to and focus on continued cost improvements and self-help initiatives exclusive of the Rite Aid merger.

Drugstore Chain CVS Poised for a Rebound

Drugstore Chain CVS Poised for a Rebound

CVS has cash on hand and is benefiting from recent acquisitions.

Trifecta Stocks Weekly Roundup

As 2016 comes to a close, we have ample cash in the portfolio to take advantage of any near-term pullback in the market.

Trifecta Stocks Weekly Roundup

We used available cash to scale into 2 portfolio positions before the Christmas holiday.

Longtime Holding CVS May Be Long in the Tooth

We might have this one on the chopping block soon, so be ready for that alert should it come out.

Find Last Minute Holiday Gifts And Essentials At CVS Pharmacy

Find Last Minute Holiday Gifts And Essentials At CVS Pharmacy

With an assortment of last minute gift ideas, stocking stuffers and everyday essentials, CVS Pharmacy takes the stress out of holiday shopping and entertaining

Trifecta Stocks Portfolio: Rate Hike, A Fed Story

Trifecta Stocks Portfolio: Rate Hike, A Fed Story

During a week that brought the long-awaited Fed interest rate increase, we exited one portfolio position.

Trifecta Stocks Weekly Roundup

During the week, we downgraded one stock's rating and exited a position as indices showed mixed performance.

How to Create Your Own Bargain

How to Create Your Own Bargain

CVS Health is an example of using LEAP options to manufacture a great entry point.

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer's 'Mad Money' Recap: How to Play Leapfrog in This Fast-Moving Market

Jim Cramer says stocks keep leapfrogging their peers in sectors like airlines and semiconductors.

CVS Posts 2017 Guidance in Line With Estimates; Share Prices Fall

CVS Posts 2017 Guidance in Line With Estimates; Share Prices Fall

The retail pharmacy and pharmacy benefit manager saw shares fall 1.7% ahead of market's open Thursday.

CVS Posts 2017 Guidance

CVS Posts 2017 Guidance

Company officials highlighted CVS' diversified lines of business as a way to manage political changes.

Downgrading CVS Health on This Morning's Analyst Day Press Release

We believe 2017 will be another challenging year for CVS, and we expect the stock to remain rangebound.

CVS Continues To Heal Its Damage

We are watching this name closely to ensure fundamentals are sound.

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Nevada

CVS Health Makes Overdose-Reversal Drug Available Without A Prescription At All CVS Pharmacy Locations In Nevada

More than 100 CVS Pharmacy locations in Nevada can now dispense naloxone

So-So Retail Sales for November

Still, the latest government data are largely favorable to the retail-related holdings in our portfolio.

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts Announce Program to Lower Insulin Prices to Avoid Mylan-Like Uproar

Eli Lilly and Express Scripts are seeking to avoid potential bad press over high insulin prices.

These 5 Stocks Are Decidedly Not Benefiting From the Trump Rally

These 5 Stocks Are Decidedly Not Benefiting From the Trump Rally

CVS Health, Estee Lauder, Express, Guess and Tyson Foods are in correction or bear market territory.

Fred's Pharmacies' Sale May Be Back on the Table

Fred's Pharmacies' Sale May Be Back on the Table

The pharmacy operator declined to take questions on a third-quarter call with investors due to a 'pending transaction.'

Rx for CVS Health: Cover Shorts, but Be Patient Before Going Long

Rx for CVS Health: Cover Shorts, but Be Patient Before Going Long

A low may be forming, but a bigger base would be needed to attract bullish investors.